FDA refuses Moderna's application for new mRNA flu vaccine, company says
Moderna received what’s called a “refusal-to-file” letter from the FDA that objected to how the company conducted a 40,000-person clinical trial comparing its new vaccine to one of the standard flu shots used today. Its a rare move by the FDA, which is under the control of Health Secretary Robert F. Kennedy Jr.
